H

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627

Watchlist Manager
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Watchlist
Price: 4.06 CNY -0.49%
Market Cap: 20.1B CNY

Intrinsic Value

The intrinsic value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is 4.98 CNY. Compared to the current market price of 4.06 CNY, Hubei Biocause Pharmaceutical Co Ltd is Undervalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
4.98 CNY
Undervaluation 18%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hubei Biocause Pharmaceutical Co Ltd

Hubei Biocause Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Hubei Biocause Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
CN
Insurance
Market Cap
20.1B CNY
IPO
Nov 12, 1996
CN
Insurance
Market Cap
20.1B CNY
IPO
Nov 12, 1996
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hubei Biocause Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Hubei Biocause Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hubei Biocause Pharmaceutical Co Ltd

Cash & Short-Term Investments 8.5B
Insurance Receivable 715m
PP&E 1.5B
Long-Term Investments 216.4B
Other Assets 58B

Wall St
Price Targets

Price Targets Summary
Hubei Biocause Pharmaceutical Co Ltd

There are no price targets for Hubei Biocause Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hubei Biocause Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Hubei Biocause Pharmaceutical Co Ltd stock?

The intrinsic value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is 4.98 CNY.

Is Hubei Biocause Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 4.06 CNY, Hubei Biocause Pharmaceutical Co Ltd is Undervalued by 18%.

Back to Top